Related Experiment Video

Updated: Jan 7, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K

Targeting STK17B: unlocking ferroptosis in myeloma

Bei Liu1

  • 1The Ohio State University Comprehensive Cancer Center.

Blood
|January 1, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K
In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation
07:03

In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation

Published on: May 6, 2020

6.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K
In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation
07:03

In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation

Published on: May 6, 2020

6.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma.

Molecular cancer research : MCR·2022

RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity.

Science advances·2020

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.

Science translational medicine·2020

Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade.

Journal of immunology (Baltimore, Md. : 1950)·2019

Regulation of dendritic cell function improves survival in experimental sepsis through immune chaperone.

Innate immunity·2019

Platelets subvert T cell immunity against cancer via GARP-TGFβ axis.

Science immunology·2017

NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

Blood·2026

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial.

Blood·2026

Human Milk Oligosaccharide (2'-FL) Modifies the Gut Microbiome in Children after Bone Marrow Transplant.

Blood·2026

Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT.

Blood·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Immune cell subsets that predict cytomegalovirus reactivation magnitude after haematopoietic stem cell transplantation.

Blood·2026

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Neuro-oncology advances·2026

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

PeerJ·2026

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

ADMET & DMPK·2026

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

MedComm·2026

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Clinical and translational radiation oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us